Post-IPO Equity Biotechnology Companies

Context Therapeutics is a clinical-stage biopharmaceutical company.

BioStem Technologies is engaged in the advancement of regenerative medicine and antiaging strategies.

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases.

Immix Biopharma is a biotech company that develops treatments for cancer and other inflammation-driven diseases.

Cantargia develops a therapy for the treatment of cancer by targeting a unique cell-surface receptor on malignant stem cells.

Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Jupiter Neurosciences is a biotechnology company that focuses on developing a treatment for Alzheimer and rare neurological disorders.

Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.

Redx Pharma is a drug discovery and development company.

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

Zentek is a nanomaterials technology company that develops graphene-based technologies.

XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease

Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

FluroTech LTD advances the science of fluorescence spectroscopy to solve unique issues and bring new, low-cost solutions to market.

Tryp Identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs.

Tevogen Bio develops immunotherapy solutions for treating cancer, neurological conditions, and viral infections.

Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.

Thiogenesis Therapeutics is a clinical-stage biotech company that develops thiol-active therapeutics to treat medical diseases.

ArriVent develops pharmaceutical products to cure presently untreatable cancer.